Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1177/0706743717720448 http://scihub22266oqcxt.onion/10.1177/0706743717720448 C5593252!5593252 !28703015     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\28703015 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Can+J+Psychiatry 2017 ; 62 (9 ): 604-616 Nephropedia Template TP {{tp|p=28703015 |t=2017. Guidelines for the Pharmacotherapy of Schizophrenia in Adults |pdf=|usr=}}{{28703015 }} gab.com Text Guidelines for the Pharmacotherapy of Schizophrenia in Adults JO: Can J Psychiatry http://www.kidney.de/pget.php?&tw=1&pmid=28703015 #FOAvip OBJECTIVE: The present guidelines address the pharmacotherapy of schizophrenia in adults across different stages, phases, and symptom domains. METHOD: Guidelines were developed using the ADAPTE process, which takes advantage of existing guidelines. Six guidelines were identified for adaptation, with recommendations extracted from each. For those specific to the pharmacotherapy of schizophrenia in adults, a working group selected between guidelines and recommendations to create an adapted guideline. RESULTS: Recommendations can be categorized into 6 areas that include 1) first-episode schizophrenia, 2) acute exacerbation, 3) relapse prevention and maintenance treatment, 4) treatment-resistant schizophrenia, 5) clozapine-resistant schizophrenia, and 6) specific symptom domains. For each category, recommendations are made based on the available evidence, which is discussed and linked to other established guidelines. CONCLUSIONS: In most cases, evidence-based recommendations are made that can be used to guide current clinical treatment and decision making. Notably, however, there is a paucity of established evidence to guide treatment decision making in the case of clozapine-resistant schizophrenia, a subsample that represents a sizable proportion of those with schizophrenia. Twit Text FOAVip Guidelines for the Pharmacotherapy of Schizophrenia in Adults ????Can J Psychiatry http://www.kidney.de/pget.php?&tw=1&pmid=28703015 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28703015 #FOAvip English Wikipedia <ref>{{Cite pmid|28703015 }}</ref> Guidelines for the Pharmacotherapy of Schizophrenia in Adults #MMPMID28703015 Remington G ; Addington D ; Honer W ; Ismail Z ; Raedler T ; Teehan M Can J Psychiatry 2017[Sep]; 62 (9 ): 604-616 PMID28703015 show ga OBJECTIVE: The present guidelines address the pharmacotherapy of schizophrenia in adults across different stages, phases, and symptom domains. METHOD: Guidelines were developed using the ADAPTE process, which takes advantage of existing guidelines. Six guidelines were identified for adaptation, with recommendations extracted from each. For those specific to the pharmacotherapy of schizophrenia in adults, a working group selected between guidelines and recommendations to create an adapted guideline. RESULTS: Recommendations can be categorized into 6 areas that include 1) first-episode schizophrenia, 2) acute exacerbation, 3) relapse prevention and maintenance treatment, 4) treatment-resistant schizophrenia, 5) clozapine-resistant schizophrenia, and 6) specific symptom domains. For each category, recommendations are made based on the available evidence, which is discussed and linked to other established guidelines. CONCLUSIONS: In most cases, evidence-based recommendations are made that can be used to guide current clinical treatment and decision making. Notably, however, there is a paucity of established evidence to guide treatment decision making in the case of clozapine-resistant schizophrenia, a subsample that represents a sizable proportion of those with schizophrenia. |Adult [MESH] |Antipsychotic Agents/*therapeutic use [MESH] |Canada [MESH] |Evidence-Based Medicine/*standards [MESH] |Humans [MESH] |Practice Guidelines as Topic/*standards [MESH]Guidelines for the Pharmacotherapy of Schizophrenia in Adults (epmc).pdf DeepDyve Pubget Overpricing